What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Related Content:

ConferenceSpecialty PharmacyOncology

FDA Grants Accelerated Approval to Enhertu for HER2 Mutant Non-small Cell Lung Cancer

Efficacy of Neoadjuvant Immunotherapy on Breast Cancer is Independent of Race

US Representatives Push Congress to Pass Legislation to Digitalize Prescribing Information for Patients, Pharmacists